NCT00206050View on ClinicalTrials.gov

Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Healthy
Interventions
DRUG

Esomeprazole

DRUG

pantoprazole

Trial Locations (1)

Unknown

Research Site, Oklahoma City

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY